Trial NCT04648319

View at ClinicalTrials.gov 
Org. Study IDs: BIO-2019-0447
Secondary IDs: CA209-7DJ

Last trial update was posted on 2022-02-23

MeSH Interventions

Nivolumab

MeSH Conditions

Cholangiocarcinoma

Other Conditions


Stopping Reasons

pharma company decision to withdraw the financial and IMP support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID